This hydrophobic interaction medium is designed for purification of recombinant hepatitis B vaccine products. It uses a six-percent agarose matrix functionalized with thiobutyl groups. The ligand provides hydrophobic binding with lower nonspecific adsorption than stronger hydrophobic media. Compatible target molecules can bind and elute at relatively low salt concentrations. This behavior supports processing of molecules with comparatively strong hydrophobic character. Spherical particles provide uniform packing and reproducible chromatography. Protein adsorption above 26 mg HSA/mL supports preparative purification. The medium operates at 250-400 cm/h under the stated pressure condition. Broad pH and chemical stability permit repeated cleaning, regeneration, and steam treatment.
Specification
Model: Butyl-S Seplife FF Appearance: White spherical gel Matrix: Seplife 6FF Ligand: Thiobutyl Shape: Spherical Particle size: 45-165 µm Pressure-flow range: 250-400 cm/h at 0.1 MPa Protein adsorption capacity:>26 mg HSA/mL Operating temperature: 4-40°C Long-term pH stability: 3-13 Short-term CIP pH stability: 2-14 Chemical compatibility: Common aqueous buffers, 1 mol/L sodium hydroxide, 70% ethanol, 50% ethylene glycol, 8 M urea, 6 mol/L guanidine hydrochloride, and 1 mM hydrochloric acid Heat resistance: 121°C in 0.1 M sodium chloride for 30 min
Features
Thiobutyl hydrophobic ligand Low nonspecific adsorption Lower-salt binding and elution 250-400 cm/h flow >26 mg/mL HSA capacity Steam-resistant matrix Wide CIP pH tolerance Designed for recombinant vaccine purification